Dioxolane cytidine

Drug Profile

Dioxolane cytidine

Alternative Names: Beta-L-Dioxolane cytidine; L-(-)-OddC; OddC

Latest Information Update: 12 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Dioxolanes
  • Mechanism of Action DNA inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 29 Nov 2000 A phase I study has been added to the Cancer pharmacokinetics section
  • 10 Oct 1997 Phase-I clinical trials for Cancer in USA (Unknown route)
  • 03 Jul 1997 A study has been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top